For OncoMed Pharmaceuticals Inc’s (NASDAQ:OMED) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. Generally, an …
Dbv Technologies S.A. (DBVT): DBVT stock is up 15.56% today. Oncomed Pharmaceuticals Inc (OMED): OMED stock is up 14.77% today. Some of the biggest losers among Manufacturing stocks include: Neonode Inc (NEON): NEON stock …
Get your Free Trial here. OncoMed Pharmaceuticals Inc. (Nasdaq: OMED) presented initial first-in-human data from its …
OMED) saw its shares crumble after the company announced that Bayer Pharma is terminating its option agreement with the company, as well as a missed mid-stage trial. After having a relatively positive year thus far, this is a huge setback …
Columbia Fds Ser Tr I-Columbia Small Cap Value Fd I 229,433 30 Jul. 2017 0.60% 777,777 Columbia Fds Var Ser Tr II-Columbia Var Port U.S. Equities Fd 152,900 29 Jun. 2017 0.40% 519,860 Columbia Fds Var Ins Tr-Columbia Var Port …
OncoMed Pharmaceuticals (NASDAQ:OMED) is an intriguing grower that has been experiencing its ups and downs. In the past 52 weeks, shares traded $0.62 lower at $3.02 for over 17% paper losses. Nevertheless, the stock is gaining …
Shares of OncoMed Pharmaceuticals Inc. OMED closed the day down 3.74% to $3.86 per share. The plunge came after both JMP JMP and Piper Jaffray PJC downgraded the company’s rating. Both firms gave the same reason for the cut: …
ABIO stock jumped over 43%, while OMED stock and IMMU stock each gained just under 8%. Finally, MACK stock tacked on nearly 7%. Of the biggest movers in the world of pharma-related small caps stocks, only OMED stock, …
OncoMed Pharmaceuticals, Inc. (OMED) saw a big move last session, as the company’s shares fell by about 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This …